ClearPoint Neuro
CLPT
96 hedge funds and large institutions have $109M invested in ClearPoint Neuro in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 31 closing their positions.
154% more call options, than puts
Call options by funds: $1.47M | Put options by funds: $579K
125% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 16
12% more capital invested
Capital invested by funds: $97.5M → $109M (+$11.8M)
3.07% more ownership
Funds ownership: 29.65% → 32.72% (+3.1%)
5% less funds holding
Funds holding: 101 → 96 (-5)
13% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$16.7M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.07M |
| 3 |
Financial Engines Advisors
Santa Clara,
California
|
+$3.15M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.61M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$8.07M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.12M |
| 3 |
Jane Street
New York
|
-$1.97M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.94M |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$1.31M |
CLPT Hedge Fund Activity: Q2 2025 in Review
96 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q2 2025, worth a combined $109M — up 12% from $97.5M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of CLPT and 27 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 36 added.
The largest buyer was BlackRock, adding an estimated $16.7M. The largest seller was Millennium Management, cutting an estimated $8.07M.
- 96 institutional investors held ClearPoint Neuro (CLPT) as of Q2 2025, down from 101 in Q1 2025.
- Funds reported $109M of ClearPoint Neuro stock for Q2 2025, up 12% quarter-over-quarter.
- 27 funds opened new ClearPoint Neuro positions in Q2 2025 and 31 closed out, a net change of -4 holders.
- The largest ClearPoint Neuro buyer in Q2 2025 was BlackRock, an estimated $16.7M added.
- The largest ClearPoint Neuro seller in Q2 2025 was Millennium Management, an estimated $8.07M sold.
Based on aggregated 13F filings for Q2 2025.